Treated and untreated maternal asthma and early pregnancy outcomes: a retrospective cohort study of 324,238 infants

Abstract Background Continued use of asthma medication during pregnancy is recommended, because asthma exacerbations often increase during pregnancy, and poor control may adversely affect maternal and foetal health. However, evidence on whether adverse outcomes arise from the treatment itself or just the underlying disease remains inconsistent. This study examined the relationship between maternal asthma, and its medication, and early pregnancy outcomes. Methods A retrospective birth cohort was constructed using population-wide linked Welsh health records of 324,238 infants born between 2009 and 2022. Logistic regression was used to investigate associations between maternal asthma (treated, untreated, and medication exposure) and pregnancy outcomes: stillbirth, iatrogenic and spontaneous preterm delivery, small/very small for gestational age (SGA/VSGA), and low Apgar score. Results Of the 324,238 infants, 39,040 (12.0%) had mothers with asthma: 20,840 (6.4%) had treated asthma, 8,230 (2.5%) had untreated asthma, and 9,970 (3.1%) were prescribed asthma medications without recorded asthma diagnoses. Compared to offspring of mothers with no maternal asthma (reference group), those whose mothers had treated asthma had higher odds of SGA (aOR 1.13, 95% CI 1.07–1.19), VSGA (aOR 1.14, 95% CI 1.03–1.26), Apgar score < 7 (aOR 1.14, 95% CI 1.01–1.29), and iatrogenic preterm delivery (aOR 1.13, 95% CI 1.01–1.26). Associations were observed across multiple classes of asthma medication with stronger associations among the offspring of mothers prescribed more than one medication class and those with add-on therapies including long-acting muscarinic antagonists, short-acting muscarinic antagonists, leukotrienes antagonist and theophylline, consistent with more severe, or poorly controlled, asthma rather than medication effects. Untreated asthma was associated with higher risk of iatrogenic preterm delivery, and treated asthma was associated with lower risk of spontaneous preterm delivery (aOR 0.81, 95% CI 0.73–0.89). No associations were observed with stillbirth. Conclusions The non-specific associations observed across different classes of asthma medication and dose-relationships with polytherapy suggested confounding by indication and severity. The findings for iatrogenic preterm delivery further supported an effect of the underlying disease rather than its treatment. These findings, together with the lower risk of spontaneous preterm delivery among treated mothers, support guideline recommendations to continue asthma treatment during pregnancy.

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2026-11-16
DOI
https://doi.org/10.1186/s12916-026-05391-w
Primary Topic
Pregnancy and Medication Impact
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Treated and untreated maternal asthma and early pregnancy outcomes: a retrospective cohort study of 324,238 infants

Scott McGill Nelson, Jill P. Pell, C. Hastie, Lama A. Shakhshir et al.
1 links
BMC Medicine
Pregnancy and Medication Impact
article

Treated and untreated maternal asthma and early pregnancy outcomes: a retrospective cohort study of 324,238 infants

Scott McGill Nelson, Jill P. Pell, C. Hastie, Lama A. Shakhshir, Michael Fleming, Sarjit Singh
article en

Abstract

Abstract Background Continued use of asthma medication during pregnancy is recommended, because asthma exacerbations often increase during pregnancy, and poor control may adversely affect maternal and foetal health. However, evidence on whether adverse outcomes arise from the treatment itself or just the underlying disease remains inconsistent. This study examined the relationship between maternal asthma, and its medication, and early pregnancy outcomes. Methods A retrospective birth cohort was constructed using population-wide linked Welsh health records of 324,238 infants born between 2009 and 2022. Logistic regression was used to investigate associations between maternal asthma (treated, untreated, and medication exposure) and pregnancy outcomes: stillbirth, iatrogenic and spontaneous preterm delivery, small/very small for gestational age (SGA/VSGA), and low Apgar score. Results Of the 324,238 infants, 39,040 (12.0%) had mothers with asthma: 20,840 (6.4%) had treated asthma, 8,230 (2.5%) had untreated asthma, and 9,970 (3.1%) were prescribed asthma medications without recorded asthma diagnoses. Compared to offspring of mothers with no maternal asthma (reference group), those whose mothers had treated asthma had higher odds of SGA (aOR 1.13, 95% CI 1.07–1.19), VSGA (aOR 1.14, 95% CI 1.03–1.26), Apgar score < 7 (aOR 1.14, 95% CI 1.01–1.29), and iatrogenic preterm delivery (aOR 1.13, 95% CI 1.01–1.26). Associations were observed across multiple classes of asthma medication with stronger associations among the offspring of mothers prescribed more than one medication class and those with add-on therapies including long-acting muscarinic antagonists, short-acting muscarinic antagonists, leukotrienes antagonist and theophylline, consistent with more severe, or poorly controlled, asthma rather than medication effects. Untreated asthma was associated with higher risk of iatrogenic preterm delivery, and treated asthma was associated with lower risk of spontaneous preterm delivery (aOR 0.81, 95% CI 0.73–0.89). No associations were observed with stillbirth. Conclusions The non-specific associations observed across different classes of asthma medication and dose-relationships with polytherapy suggested confounding by indication and severity. The findings for iatrogenic preterm delivery further supported an effect of the underlying disease rather than its treatment. These findings, together with the lower risk of spontaneous preterm delivery among treated mothers, support guideline recommendations to continue asthma treatment during pregnancy.

BMC Medicine
University of Glasgow (GB)
Health Data Research UK
Good health and well-being
Pregnancy and Medication Impact
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon